Suven Life Sciences Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Suven Life Sciences Share Price

260.80-8.00 (-2.98%)

Live
As On: 11 Jun, 2026, 01:43 PM IST
As On: 11 Jun, 2026, 01:43 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	265.15
High	270.35
Low	260.05
Prev Close	268.80
Volume	5,93,734
VWAP(₹)	264.61

Key Metrics

PE Ratio(x)	-24.93
EPS - TTM(₹)	-10.48
MCap(₹ Cr.)	6,894.97
MCap Rank	55
PB Ratio(x)	11.98
Div Yield(%)	-
Face Value(₹)	1.00
52W High(₹)	299.99
52W Low(₹)	124.11
MCap/Sales	492.58
Beta(1 Month)	1.14
BV/Share(₹)	22.43

Suven Life Sci share price insights

Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
PAT: Troublesome Times
Company has posted a loss of Rs 45.6 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 19.89% outperformed its 3 year CAGR of -1.44%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.22% of its operating revenues towards interest expenses and 339.43% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Suven Life Sci Share Price Update
Suven Life Sciences Ltd. share price moved down by -2.98% from its previous close of Rs 268.80. Suven Life Sciences Ltd. stock last traded price is 260.80
Share Price Value
Today/Current/Last 260.80261.05
Previous Day 268.80268.70

Found Insights useful?

Suven Life Sci Share Price Returns

1 Day	-2.98%
1 Month	19.73%
3 Months	84.53%
1 Year	5.58%
3 Years	332.86%
5 Years	162.24%

Suven Life Sci Share Recommendations

Recent Recos

Target₹445
OrganizationKotak Securities Limited
BUY

Target₹387
OrganizationAnand Rathi
BUY

Target₹312
OrganizationIndependent Analyst
BUY

View all Stock Recommendations

News & Analysis

View all Suven Life Sci Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	8.30	5.58	4.70	2.47	2.69
Total Income Growth (%)	48.62	18.86	90.44	-8.29	-17.00
Total Expenses	53.74	107.51	82.01	53.98	46.63
Total Expenses Growth (%)	-50.02	31.09	51.91	15.76	10.12
EBIT	-45.44	-101.92	-77.31	-51.52	-43.94
EBIT Growth (%)	-	-	-	-	-
Profit after Tax (PAT)	-45.60	-101.92	-77.31	-51.52	-43.94
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	-547.58	-1,825.51	-1,645.87	-2,088.66	-1,633.94
Net Profit Margin (%)	-549.48	-1,825.51	-1,645.87	-2,088.66	-1,633.94
Basic EPS (₹)	-2.02	-4.55	-3.48	-2.36	-2.02

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	8.30	5.57	4.70	2.46	2.66
Total Income Growth (%)	48.85	18.68	91.27	-7.60	-16.40
Total Expenses	19.31	19.05	20.14	17.23	17.73
Total Expenses Growth (%)	1.37	-5.44	16.87	-2.78	7.81
EBIT	-11.01	-13.47	-15.45	-14.78	-15.07
EBIT Growth (%)	-	-	-	-	-
Profit after Tax (PAT)	-11.17	-13.47	-15.45	-14.78	-15.07
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	-132.68	-241.66	-328.83	-601.81	-567.01
Net Profit Margin (%)	-134.58	-241.66	-328.83	-601.81	-567.01
Basic EPS (₹)	-0.50	-0.60	-0.70	-0.68	-0.69

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	21.04	17.55	32.82	21.99	17.16
Total Revenue Growth (%)	19.89	-46.52	49.28	28.13	-19.17
Total Expenses	297.39	178.30	146.36	146.26	139.16
Total Expenses Growth (%)	66.79	21.82	0.07	5.10	40.98
Profit after Tax (PAT)	-276.34	-160.75	-105.08	-118.27	-122.00
PAT Growth (%)	-	-	-	-	-
Operating Profit Margin (%)	-3,881.91	-2,414.41	-969.62	-915.70	-1,025.51
Net Profit Margin (%)	-3,884.12	-2,415.11	-898.63	-873.52	-1,029.98
Basic EPS (₹)	-12.13	-7.37	-4.82	-6.63	-9.57

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	21.03	17.38	32.82	21.99	17.16
Total Revenue Growth (%)	20.96	-47.04	49.28	28.13	-19.17
Total Expenses	75.89	64.46	49.29	48.12	53.41
Total Expenses Growth (%)	17.73	30.78	2.44	-9.91	8.59
Profit after Tax (PAT)	-54.86	-47.08	-8.01	-20.13	-36.25
PAT Growth (%)	-	-	-	-	-
Operating Profit Margin (%)	-768.90	-706.64	-139.47	-190.83	-301.56
Net Profit Margin (%)	-771.11	-707.34	-68.48	-148.65	-306.04
Basic EPS (₹)	-2.41	-2.16	-0.37	-1.13	-2.84

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Troublesome Times
Company has posted a loss of Rs 45.6 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 19.89% outperformed its 3 year CAGR of -1.44%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	624.21	135.18	284.90	388.91	108.03
Total Assets Growth (%)	361.75	-52.55	-26.74	259.99	-15.87
Total Liabilities	32.81	25.20	14.86	13.59	11.89
Total Liabilities Growth (%)	30.23	69.54	9.35	14.32	-41.75
Total Equity	591.40	109.99	270.04	375.32	96.15
Total Equity Growth (%)	437.70	-59.27	-28.05	290.37	-10.98
Current Ratio (x)	17.69	3.21	18.99	22.61	8.01
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.01
Contingent Liabilities	0.00	6.17	4.28	-	-

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,531.06	808.89	851.48	860.44	486.35
Total Assets Growth (%)	89.28	-5.00	-1.04	76.92	17.08
Total Liabilities	27.70	9.38	6.11	7.00	10.38
Total Liabilities Growth (%)	195.31	53.52	-12.71	-32.56	-24.40
Total Equity	1,503.37	799.51	845.38	853.44	475.98
Total Equity Growth (%)	88.04	-5.43	-0.94	79.30	18.51
Current Ratio (x)	63.15	7.52	51.70	53.18	9.44
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	6.17	4.28	-	-

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-301.79	-154.10	-115.47	-103.15	-127.54
Net Cash used in Investing Activities	-462.11	154.95	94.44	-260.65	-22.23
Net Cash flow from Financing Activities	757.15	-0.76	-1.05	395.54	145.69
Net Cash Flow	-6.75	0.09	-22.09	31.75	-4.07
Closing Cash & Cash Equivalent	8.28	15.03	14.93	37.02	5.27
Closing Cash & Cash Equivalent Growth (%)	-44.90	0.62	-59.66	601.97	-43.59
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-69.60	-47.39	-20.56	-10.09	-36.62
Net Cash used in Investing Activities	-685.74	44.21	-0.68	-361.66	-107.46
Net Cash flow from Financing Activities	757.15	-0.76	-1.05	395.54	145.69
Net Cash Flow	1.82	-3.94	-22.30	23.79	1.61
Closing Cash & Cash Equivalent	2.28	0.46	4.40	26.70	2.90
Closing Cash & Cash Equivalent Growth (%)	392.19	-89.47	-83.52	820.40	124.72
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	-0.01

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-46.72	-146.14	-38.91	-31.51	-126.88
Return on Capital Employed (%)	-46.54	-143.86	-41.77	-32.81	-121.80
Return on Assets (%)	-44.27	-118.90	-36.88	-30.41	-112.92
Interest Coverage Ratio (x)	-1,714.66	-3,323.53	-674.71	-406.21	-220.85
Asset Turnover Ratio (x)	0.02	0.03	0.03	0.03	0.04
Price to Earnings (x)	-12.69	-15.38	-20.70	-8.94	-11.06
Price to Book (x)	5.92	22.48	8.05	2.82	14.02
EV/EBITDA (x)	-11.70	-15.72	-18.81	-7.43	-11.47
EBITDA Margin (%)	-3,803.01	-2,326.94	-914.01	-867.37	-988.42

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-3.64	-5.88	-0.94	-2.35	-7.61
Return on Capital Employed (%)	-3.59	-5.87	-1.92	-3.01	-7.44
Return on Assets (%)	-3.58	-5.82	-0.94	-2.33	-7.45
Interest Coverage Ratio (x)	-311.10	-884.37	-61.91	-66.74	-59.09
Asset Turnover Ratio (x)	0.01	0.01	0.01	0.02	0.03
Price to Earnings (x)	-64.10	-52.63	-277.78	-52.63	-37.31
Price to Book (x)	2.33	3.09	2.57	1.24	2.83
EV/EBITDA (x)	-64.62	-59.52	-206.06	-45.77	-42.96
EBITDA Margin (%)	-690.00	-619.18	-83.86	-142.51	-264.47

Insights

Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Stock doesn't have any Revenue Forecast Data
EARNINGS
Stock doesn't have any Earning Forecast Data
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Suven Life Sci	-24.93	11.65	-46.72	-46.54	-44.27	-1.44	-3,881.91	-3,884.12	-12.13	17.69	0.00	0.00
Sequent Scientific	91.10	3.50	6.08	12.55	3.83	33.99	13.52	6.56	4.09	2.38	0.15	1.35
Supriya Lifescience	36.44	6.36	17.45	22.42	15.40	21.05	33.47	25.25	25.98	4.40	0.00	0.00
Sun Pharma Adv Res.	4.30	4.98	116.01	112.89	71.54	95.04	85.11	82.65	47.86	2.47	0.42	-2.33
Innova Captab	39.03	5.04	12.91	15.27	7.66	20.29	12.58	8.64	24.63	1.87	0.31	2.94
Add More

Annual Ratios (%)

Choose from Peers

Orchid Pharma
Zota Healthcare
Gujarat Themis
RPG Life Sci
Aarti Drugs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 18,50,00,000 70.15 % 2.79
Pledge 0 0.00 % 0.00
FII 23,92,588 0.91 % -0.16
DII 1,21,85,090 4.62 % 1.23
MF 47,22,478 1.79 % -0.29
Others 6,41,42,905 24.31 % -3.86
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 70.15 67.36 67.36 70.27
Pledge 0.00 0.00 0.00 0.00
FII 0.91 1.07 1.17 0.58
DII 4.62 3.39 3.39 0.02
Mutual Funds 1.79 2.08 2.08 0.01
Others 24.31 28.18 28.08 29.13

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Quant Small Cap Direct-G
Equity: Small Cap
3
- 99.62
  Amount Invested (in Cr.)
- 0.327965%
  % of AUM
- 0.00
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.04
  Amount Invested (in Cr.)
- 0.09797057%
  % of AUM
- -3.73
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.1%
  % of AUM
- 5.94
  % Change (MoM basis)

View all Mutual Fund Schemes

Suven Life Sci Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results
May 06, 2026
Board Meeting
Quarterly Results
Jan 22, 2026
Board Meeting
Quarterly Results
Nov 03, 2025

Announced on	Meeting on
May 06, 2026	May 13, 2026
Audited Results
Jan 22, 2026	Jan 29, 2026
Quarterly Results
Nov 03, 2025	Nov 11, 2025
Quarterly Results
Aug 05, 2025	Aug 13, 2025
Quarterly Results
May 06, 2025	May 13, 2025
Audited Results & Preferential issue

Dividends
Announced on Ex-Date Dividend%
Jan 29, 2019 Feb 14, 2019 150%
Jan 19, 2018 Feb 06, 2018 150%
Jan 23, 2017 Feb 08, 2017 100%
Mar 08, 2016 Mar 14, 2016 100%
Mar 02, 2016 Mar 14, 2016 100%
Bonus
Announced on Ex-Date
Jan 29, 2007 Mar 23, 2007
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
Announced on Ex-Date
Jan 29, 2007 Mar 23, 2007
Split: Old FV2.0| New FV:1.0
Dec 04, 2003 Jan 15, 2004
Split: Old FV10.0| New FV:2.0
Rights
Announced on Ex-Date
Jun 24, 2022 Oct 17, 2022
Rights ratio: 1 share for every 2 held at a price of Rs 55.0

AGM/EGM Meetings

Announced on	Meeting on
Jul 30, 2025	Aug 22, 2025
-
May 14, 2025	Jun 05, 2025
-
May 06, 2024	Aug 02, 2024
Book closure from Jul 31, 2024 to Aug 2, 2024
Feb 02, 2024	Mar 07, 2024
-
May 09, 2023	Aug 05, 2023
Book closure from Aug 3, 2023 to Aug 5, 2023

About Suven Life Sci

Suven Life Sciences Ltd., incorporated in the year 1989, is a Mid Cap company (having a market cap of Rs 7,088.81 Crore) operating in Pharmaceuticals sector.

Suven Life Sciences Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 8.30 Crore, up 48.62 % from last quarter Total Income of Rs 5.58 Crore and up 208.53 % from last year same quarter Total Income of Rs 2.69 Crore. Company has reported net profit after tax of Rs -45.60 Crore in latest quarter.

The company’s top management includes Mr.Venkateswarlu Jasti, Mrs.Sudharani Jasti, Mrs.J A S Padmaja, Mr.Santanu Mukherjee, Prof.Seyed E Hasnain, Dr.Vajja Sambasiva Rao, Mr.M Mohan Kumar, Mr.Shrenik Soni. Company has Tukaram & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 26.37 Crore shares outstanding.

Suven Life Sci Share Price Today is Rs. 260.80. On previous day, the Suven Life Sci Share Price (NSE) closed at Rs. 264.45, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 70.15% of the stake in Suven Life Sci shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Suven Life Sci stocks was 0.91% as compared to 1.07% in Dec 2025 with decrease of 0.16%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 4.62% as compared to 3.39% in Dec 2025 with increase of 1.23%. Out of the total DII holdings in Suven Life Sci shares 1.79% was held by mutual funds. The rest including public held is 24.32%. Suven Life Sci stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Suven Life Sci Dividend: Ever since 1989, Suven Life Sci dividends has been paid out around 26 times. As on 11 Jun, 2026, 01:43 PM IST, The overall dividend yield for Suven Life Sci stands at 0.0%. The last dividend paid was on February 14, 2019 (Rs. 1.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -10.48.

Suven Life Sci Bonus: The most recent bonus issue had been in year March 23, 2007 around 19 years ago at 1 : 1 ratio. The first bonus issue was announced in Jan 2007.

Stock Forecast:
After showing 8.3 Cr. of sales and 48.62% of quarterly net profit, there have been multiple ups and downs in the Suven Life Sci stock prices in the past few weeks. For example, Suven Life Sci stock price on 3rd of June 2026 was around Rs. 275.35. Suven Life Sci share price now stands at an average of Rs. 260.80. Judging by last week's performance, stock is in down trend.

Suven Life Sci has a median target price of Rs. 281.97 in 12 months by 1 analysts. They have provided a high estimate of Rs. 281.97 and low estimate of Rs. 281.97 for Suven Life Sci share.

Historical Prices and Performance:
Suven Life Sci, incorporated in 1989 is a Mid Cap company (with a market cap of Rs. 7088.81) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Suven Life Sci stock was -46.72%, -146.14%, -38.91%, -31.51% and -126.88% respectively.
The Suven Life Sci share gave a 3 year return of 346.14% as compared to Nifty 50 which gave a return of 25.06%.
Suven Life Sci announced 150.0% final dividend on February 14, 2019.

Key Metrics:
PE Ratio of Suven Life Sci is -25.24
Prices/Sales Ratio of Suven Life Sci is 492.58
Price/Book Ratio of Suven Life Sci is 11.79

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Suven Life Sci, major competitors and peers include Sequent Scientific, Supriya Lifescience, Sun Pharma Adv Res. and Innova Captab. As of Dec 2025, the dividend yield of Suven Life Sci stands at 0.0% while Sequent Scientific, Supriya Lifescience, Sun Pharma Adv Res. and Innova Captab stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -25.24 and 11.79 respectively.

Leadership of Suven Life Sci :
M Mohan Kumar is Chief Financial Officer
Shrenik Soni is Co. Secretary & Compl. Officer
Venkateswarlu Jasti is Chairman & Managing Director
Sudharani Jasti is Whole Time Director
Seyed E Hasnain is Director
Santanu Mukherjee is Director
J A S Padmaja is Director
Vajja Sambasiva Rao is Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

8-2-334, SDE Serene Chambers,6th Floor, Avenue 7,Road No. 5, Banjara Hills,Hyderabad, Telangana - 500034

Contact

http://www.suven.com

Executive Leadership

VJ

Venkateswarlu Jasti

Chairman & Managing Director

SJ

Sudharani Jasti

Whole Time Director

JA

J A S Padmaja

Director

SM

Santanu Mukherjee

Director

Show More

Auditors

Karvy & Co.

Tukaram & Co. LLP

FAQs about Suven Life Sci share

1. What's Suven Life Sci share price today and what are Suven Life Sci share returns ?
As on 11 Jun, 2026, 01:43 PM IST Suven Life Sci share price is down by 2.98% basis the previous closing price of Rs 264.45. Suven Life Sci share price is Rs 260.80. Return Performance of Suven Life Sci Shares:
- 1 Week: Suven Life Sci share price moved down by 2.08%
2. What is the PE & PB ratio of Suven Life Sci?
The PE ratio of Suven Life Sci stands at -25.65, while the PB ratio is 11.99.
3. What's the market capitalization of Suven Life Sci?
Suven Life Sci share has a market capitalization of Rs 6,894.97 Cr. Within Pharmaceuticals sector, it's market cap rank is 55.
4. What is Suven Life Sci's 52 week high / low?
Suven Life Sci share price saw a 52 week high of Rs 299.99 and 52 week low of Rs 124.11.
5. What are the returns for Suven Life Sci share?
Return Performance of Suven Life Sci Shares:
- 1 Week: Suven Life Sci share price moved down by 2.08%

Top Gainers

As on 01:42 PM | 11 Jun 2026

Aegis Logistics

901.60

100.61 (12.56%)

DOMS Industries

2,265.00

146.41 (6.92%)

Blue Jet Healthcare

500.00

30.25 (6.44%)

1,919.00

86.00 (4.70%)

Apar Industries

14,705.00

620.00 (4.41%)

Top Losers

As on 01:42 PM | 11 Jun 2026

Ola Electric Mobilit

44.59

-2.73 (-5.77%)

165.65

-9.25 (-5.29%)

155.64

-7.99 (-4.88%)

Netweb Technologies

4,089.70

-205.91 (-4.80%)

1,137.50

-55.91 (-4.69%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.